NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+7.46%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.91B
AUM Growth
+$1.91B
(-13%)
Cap. Flow
-$460M
Cap. Flow
% of AUM
-24%
Top 10 Holdings %
Top 10 Hldgs %
80.8%
Holding
37
New
1
Increased
1
Reduced
7
Closed
3
Top Buys
| 1 |
Ardelyx
ARDX
|
$74.6M |
| 2 |
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
|
$11.8M |
Top Sells
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$115M |
| 2 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$109M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$100M |
| 4 |
CVT
CVENT, INC.
CVT
|
$71M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$58.8M |
Sector Composition
| 1 | Healthcare | 71.57% |
| 2 | Communication Services | 12.3% |
| 3 | Technology | 8.35% |
| 4 | Consumer Discretionary | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$697M
| $10.4M | 0.54% | 3,243,150 | – | – |
|
|
ROKA
27
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $8.37M | 0.44% | 3,220,433 | – | – |
|
28
Exelixis
EXEL
$10.1B
| $8.3M | 0.43% | 2,207,000 | – | – |
|
29
Aurinia Pharmaceuticals
AUPH
$1.58B
| $7.69M | 0.4% | 2,546,843 | – | – |
|
|
ECOM
30
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $6.65M | 0.35% | 556,692 | – | – |
|
|
CVT
31
DELISTED
CVENT, INC.
CVT
| $6.29M | 0.33% | 244,106 -2,752,632 | -92% | -$71M |
|
|
PRTK
32
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.48M | 0.23% | 173,892 | – | – |
|
|
ARQL
33
DELISTED
Arqule Inc
ARQL
| $4.03M | 0.21% | 2,520,316 | – | – |
|
|
AGRX
34
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.15M | 0.06% | 133,488 | – | – |
|
|
NURO
35
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| – | – | -57,273 | Closed | -$96K |
|
|
WIFI
36
DELISTED
Boingo Wireless, Inc.
WIFI
| – | – | -2,496,312 | Closed | -$18.8M |
|
|
HPTX
37
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| – | – | -2,384,221 | Closed | -$109M |
|